Edex Injection, Powder, Lyophilized, For Solution
Product Images NDC 52244-010

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Edex (NDC 52244-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Endo Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Alprostadil Chemical Structure (Edex 1)

Chemical structure of alprostadil, the active ingredient in Edex injection, lyophilized powder for solution, commonly used by intracavernous route. The diagram shows the molecular bonds and arrangement of atoms characteristic to alprostadil.*

FDA Label Image

α-cyclodextrin Chemical Structure (Edex 2)

Chemical structure diagram of alprostadil, the active ingredient in Edex injection. The structure depicts the molecular arrangement as presented in the product's FDA labeling data.*

FDA Label Image

Figure A (Edex 3)

An instructional diagram labeled 'Figure A' showing components of the Edex injection cartridge supplies for self-injection. It identifies parts including an external protective cap, internal protective cap, needle, colored tip, upper chamber with drug, upper stopper, bottom chamber with diluent, lower stopper, reusable injection device, blue portion of plunger, plunger, and two alcohol swabs.*

FDA Label Image

Figure B (Edex 4)

An instructional illustration showing two hands opening a vial or small container by twisting or pulling apart the top, labeled as Figure B. It appears to be part of a sequence demonstrating preparation steps for a medication or injection.*

FDA Label Image

Figure C (Edex 5)

An instructional diagram showing a person preparing an injection by attaching or removing a needle from a syringe. The illustration uses arrows to indicate the proper sequence of steps for connecting the syringe and needle, relevant for proper drug administration technique.*

FDA Label Image

Figure D (Edex 6)

An instructional diagram labeled 'Figure D' showing hands assembling or preparing a medical injection device. The illustration highlights two steps: removing a cap or cover and connecting components, intended for proper use of the injection product.*

FDA Label Image

Figure E (Edex 7)

An instructional line drawing showing two hands preparing a vial. One hand holds the vial steady while the other hand is uncapping or manipulating the stopper or top of the vial, illustrating a step in medication preparation, likely for injection administration.*

FDA Label Image

Figure F (Edex 8)

An instructional illustration showing a hand holding a syringe and another hand inserting a cartridge or vial into the syringe, likely depicting preparation of an injection. The image is labeled as Figure F and demonstrates a step in the assembly or filling process for a drug injection device.*

FDA Label Image

Figure G (Edex 9)

Illustration demonstrating how to prepare a syringe for injection, showing a hand removing or adjusting a component with numbered steps for guidance. The image is related to the administration or preparation process of the injectable drug Edex (alprostadil).*

FDA Label Image

Figure H (Edex 10)

An instructional illustration showing a hand holding a syringe with a needle cover being pulled off, indicated by upward arrows. This likely demonstrates part of the preparation or administration process for Edex injection, alprostadil lyophilized powder for solution, intended for intracavernous use.*

FDA Label Image

Figure I (Edex 11)

An instructional illustration showing a hand holding a vial and a syringe. The image demonstrates the steps to attach or remove the vial cap from the syringe, indicated by numbered arrows (1 and 2) guiding the motion. This diagram is part of preparation instructions for the Edex injection, alprostadil lyophilized powder for solution.*

FDA Label Image

Figure J (Edex 12)

An instructional illustration showing a hand flicking a syringe labeled with measurement marks to expel air bubbles from the syringe prior to injection.*

FDA Label Image

Figure K (Edex 13)

An instructional illustration showing a hand holding a syringe with a plunger being pulled up, possibly demonstrating how to prepare or draw medication for injection. The syringe barrel is detailed with volume markings enlarged in a zoom-in circle to highlight measurement levels.*

FDA Label Image

Figure L (Edex 14)

An instructional illustration demonstrating how to apply or position a strip of tape on a body part, likely related to use or post-use care instructions for a pharmaceutical injection product.*

FDA Label Image

Figure M (Edex 15)

An instructional line drawing showing a hand holding a syringe and injecting into the thumb of the opposite hand. The illustration appears to demonstrate a step related to intracavernous injection technique.*

FDA Label Image

Figure N (Edex 16)

An instructional illustration depicting a person holding a syringe with a blue needle cap, preparing to inject. The image shows the positioning of both hands for administering an injection, likely related to Edex (alprostadil) intracavernous injection solution.*

FDA Label Image

Figure O (Edex 17)

An instructional line drawing depicting a hand holding a cylindrical object partially wrapped in material, illustrating a step involving manual manipulation or application of the object, labeled as Figure 0.*

FDA Label Image

10 Mcg 2 Pk (Edex 18)

Label for Edex 10 mcg injection, powder, lyophilized, for solution containing alprostadil. It is a sterile powder and diluent (0.9% sodium chloride) in a cartridge for intracavernous injection. The label indicates prescription use and lists Endo Pharmaceuticals Inc. as the distributor.*

FDA Label Image

10 Mcg 6 Pk (Edex 19)

Box label for Edex 10 mcg (alprostadil for injection) cartridge 2 pack. The dosage form is sterile powder and diluent in cartridges for intracavernous injection. The label states it contains an Edex injection device and supplies for 2 single doses. Manufactured by Vetter Pharma and distributed by Endo Pharmaceuticals, Inc.*

FDA Label Image

20 Mcg 2pk (Edex 20)

Edex 20 mcg injection powder and diluent label showing alprostadil for injection. It specifies sterile powder and diluent (sterile 0.9% sodium chloride injection) in cartridge for intracavernous injection. Distributed by Endo Pharmaceuticals Inc., Malvern, PA. The NDC code 52244-020-01 is visible.*

FDA Label Image

20 Mcg 6pk (Edex 21)

Edex 20 mcg (alprostadil for injection) cartridge 2 pack carton for intracavernous injection. The label states sterile powder and diluent in 0.9% sodium chloride for injection, containing an injection device and supplies for 2 single-doses. Manufactured by Vetter Pharma and distributed by Endo Pharmaceuticals, with storage and handling instructions included.*

FDA Label Image

40 Mcg 2pk (Edex 22)

Label of Edex 40 mcg alprostadil for injection, showing it as a sterile powder and diluent in cartridge form for intravernous injection. Distributed by Endo Pharmaceuticals Inc., Malvern, PA. The label includes NDC 52244-040-01 and shows the product is for prescription use only.*

FDA Label Image

40 Mcg 2pk (Edex 23)

Packaging label for Edex 40 mcg (alprostadil for injection) cartridge 2 pack. The label states it contains sterile powder and diluent in cartridges for intracavernous injection, and includes an injection device and supplies for two single-doses. Manufactured by Vetter Pharma and distributed by Endo Pharmaceuticals Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.